JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Uhde, I.
Right arrow Articles by Schwanstecher, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uhde, I.
Right arrow Articles by Schwanstecher, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 40, 28079-28082, October 1, 1999

COMMUNICATION
Identification of the Potassium Channel Opener Site on Sulfonylurea Receptors

Ingo Uhde, Andreas Toman, Insa Gross, Christina Schwanstecher, and Mathias Schwanstecher

From the Institut für Pharmakologie und Toxikologie, Universität Braunschweig, Mendelssohnstraße 1, 38106 Braunschweig, Germany

Diversity of sulfonylurea receptor (SUR) subunits underlies tissue specific pharmacology of KATP channels, which represent critical regulators of electrical activity in numerous cells. Notably, the neuronal/pancreatic beta -cell receptor, SUR1, imparts high sensitivity to hypoglycemic sulfonylureas (SUs; e.g. glibenclamide) and low to potassium channel openers (KCOs; e.g. P1075), whereas the opposite drug sensitivities are conferred by cardiovascular receptors, SUR2A and SUR2B. By exchanging domains between SUR1 and SUR2B, we identify two regions (KCO I: Thr1059-Leu1087 and KCO II: Arg1218-Asn1320; rat SUR2 numbering) within the second set of transmembrane domains (TMDII) as critical for KCO binding. Swapping both regions reconstitutes KCO affinities and sensitivities of the donor SUR isoform. High glibenclamide affinity of SUR1 is not reduced by transfer of KCO I plus II from SUR2B, demonstrating that high SU and KCO affinity can coexist in the same SUR molecule. Consistently, high SU affinity was imparted on SUR2B by substituting the region separating KCO I and II (Ile1088-Val1217) with the corresponding domain of SUR1. We infer the receptor sites for KCOs and SUs to be closely associated within a regulatory domain (Thr1059-Asn1320) in TMDII of SURs.


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
T. Farzaneh and A. Tinker
Differences in the mechanism of metabolic regulation of ATP-sensitive K+ channels containing Kir6.1 and Kir6.2 subunits
Cardiovasc Res, September 1, 2008; 79(4): 621 - 631.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Physiol.Home page
A. B. Karger, S. Park, S. Reyes, M. Bienengraeber, R. B. Dyer, A. Terzic, and A. E. Alekseev
Role for SUR2A ED Domain in Allosteric Coupling within the KATP Channel Complex
J. Gen. Physiol., February 25, 2008; 131(3): 185 - 196.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Suzuki, Y. Makita, T. Mukai, K. Matsuo, O. Ueda, and K. Fujieda
Molecular Basis of Neonatal Diabetes in Japanese Patients
J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3979 - 3985.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Winkler, D. Stephan, S. Bieger, P. Kuhner, F. Wolff, and U. Quast
Testing the Bipartite Model of the Sulfonylurea Receptor Binding Site: Binding of A-, B-, and A + B-Site Ligands
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 701 - 708.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S.-P. Tam, L. Mok, G. Chimini, M. Vasa, and R. G. Deeley
ABCA1 mediates high-affinity uptake of 25-hydroxycholesterol by membrane vesicles and rapid efflux of oxysterol by intact cells
Am J Physiol Cell Physiol, September 1, 2006; 291(3): C490 - C502.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Moreau, F. Gally, H. Jacquet-Bouix, and M. Vivaudou
The Size of a Single Residue of the Sulfonylurea Receptor Dictates the Effectiveness of KATP Channel Openers
Mol. Pharmacol., April 1, 2005; 67(4): 1026 - 1033.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Bancila, T. Cens, D. Monnier, F. Chanson, C. Faure, Y. Dunant, and A. Bloc
Two SUR1-specific Histidine Residues Mandatory for Zinc-induced Activation of the Rat KATP Channel
J. Biol. Chem., March 11, 2005; 280(10): 8793 - 8799.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Bryan, W. H. Vila-Carriles, G. Zhao, A. P. Babenko, and L. Aguilar-Bryan
Toward Linking Structure With Function in ATP-Sensitive K+ Channels
Diabetes, December 1, 2004; 53(suppl_3): S104 - S112.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Hambrock, T. Kayar, D. Stumpp, and H. Osswald
Effect of Two Amino Acids in TM17 of Sulfonylurea Receptor SUR1 on the Binding of ATP-Sensitive K+ Channel Modulators
Diabetes, December 1, 2004; 53(suppl_3): S128 - S134.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. J. DUNNE, K. E. COSGROVE, R. M. SHEPHERD, A. AYNSLEY-GREEN, and K. J. LINDLEY
Hyperinsulinism in Infancy: From Basic Science to Clinical Disease
Physiol Rev, January 1, 2004; 84(1): 239 - 275.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Davis-Taber, E. J. Molinari, R. J. Altenbach, K. L. Whiteaker, C.-C. Shieh, G. Rotert, S. A. Buckner, J. Malysz, I. Milicic, J. S. McDermott, et al.
[125I]A-312110, a Novel High-Affinity 1,4-Dihydropyridine ATP-sensitive K+ Channel Opener: Characterization and Pharmacology of Binding
Mol. Pharmacol., July 1, 2003; 64(1): 143 - 153.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. A. Cartier, S. Shen, and S.-L. Shyng
Modulation of the Trafficking Efficiency and Functional Properties of ATP-sensitive Potassium Channels through a Single Amino Acid in the Sulfonylurea Receptor
J. Biol. Chem., February 21, 2003; 278(9): 7081 - 7090.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. P. Babenko and J. Bryan
SUR-dependent Modulation of KATP Channels by an N-terminal KIR6.2 Peptide. DEFINING INTERSUBUNIT GATING INTERACTIONS
J. Biol. Chem., November 8, 2002; 277(46): 43997 - 44004.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Hambrock, R. Preisig-Muller, U. Russ, A. Piehl, P. J. Hanley, J. Ray, J. Daut, U. Quast, and C. Derst
Four novel splice variants of sulfonylurea receptor 1
Am J Physiol Cell Physiol, August 1, 2002; 283(2): C587 - C598.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Dabrowski, F. M. Ashcroft, R. Ashfield, P. Lebrun, B. Pirotte, J. Egebjerg, J. Bondo Hansen, and P. Wahl
The Novel Diazoxide Analog 3-Isopropylamino-7-Methoxy-4H-1,2,4-Benzothiadiazine 1,1-Dioxide Is a Selective Kir6.2/SUR1 Channel Opener
Diabetes, June 1, 2002; 51(6): 1896 - 1906.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Loffler-Walz, A. Hambrock, and U. Quast
Interaction of KATP Channel Modulators with Sulfonylurea Receptor SUR2B: Implication for Tetramer Formation and Allosteric Coupling of Subunits
Mol. Pharmacol., February 1, 2002; 61(2): 407 - 414.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
U. Russ, U. Lange, C. Loffler-Walz, A. Hambrock, and U. Quast
Interaction of the Sulfonylthiourea HMR 1833 with Sulfonylurea Receptors and Recombinant ATP-Sensitive K+ Channels: Comparison with Glibenclamide
J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 1049 - 1055.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
F. Reimann, F. M. Ashcroft, and F. M. Gribble
Structural Basis for the Interference Between Nicorandil and Sulfonylurea Action
Diabetes, October 1, 2001; 50(10): 2253 - 2259.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
A. Hambrock, C. Loffler-Walz, U. Russ, U. Lange, and U. Quast
Characterization of a Mutant Sulfonylurea Receptor SUR2B with High Affinity for Sulfonylureas and Openers: Differences in the Coupling to Kir6.x Subtypes
Mol. Pharmacol., July 1, 2001; 60(1): 190 - 199.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
T. Krauter, J. P. Ruppersberg, and T. Baukrowitz
Phospholipids as Modulators of KATP Channels: Distinct Mechanisms for Control of Sensitivity to Sulphonylureas, K+ Channel Openers, and ATP
Mol. Pharmacol., April 16, 2001; 59(5): 1086 - 1093.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
F. Reimann, F. M. Gribble, and F. M. Ashcroft
Differential Response of KATP Channels Containing SUR2A or SUR2B Subunits to Nucleotides and Pinacidil
Mol. Pharmacol., April 13, 2001; 58(6): 1318 - 1325.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
B. O'Rourke
Myocardial KATP Channels in Preconditioning
Circ. Res., November 10, 2000; 87(10): 845 - 855.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Matsuoka, K. Matsushita, Y. Katayama, A. Fujita, K. Inageda, M. Tanemoto, A. Inanobe, S. Yamashita, Y. Matsuzawa, and Y. Kurachi
C-Terminal Tails of Sulfonylurea Receptors Control ADP-Induced Activation and Diazoxide Modulation of ATP-Sensitive K+ Channels
Circ. Res., November 10, 2000; 87(10): 873 - 880.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. BIENENGRAEBER, A. E. ALEKSEEV, M. R. ABRAHAM, A. J. CARRASCO, C. MOREAU, M. VIVAUDOU, P. P. DZEJA, and A. TERZIC
ATPase activity of the sulfonylurea receptor: a catalytic function for the KATP channel complex
FASEB J, October 1, 2000; 14(13): 1943 - 1952.
[Abstract] [Full Text]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
R. M Shepherd, K. E Cosgrove, R. E O'Brien, P. D Barnes, C. Ämmälä, and M. J Dunne
Hyperinsulinism of infancy: towards an understanding of unregulated insulin release
Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2000; 82(2): 87F - 97.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. P. Babenko, G. Gonzalez, and J. Bryan
Pharmaco-topology of Sulfonylurea Receptors. SEPARATE DOMAINS OF THE REGULATORY SUBUNITS OF KATP CHANNEL ISOFORMS ARE REQUIRED FOR SELECTIVE INTERACTION WITH K+ CHANNEL OPENERS
J. Biol. Chem., January 14, 2000; 275(2): 717 - 720.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
I. Gross, A. Toman, I. Uhde, C. Schwanstecher, and M. Schwanstecher
ACCELERATED COMMUNICATION: Stoichiometry of Potassium Channel Opener Action
Mol. Pharmacol., December 1, 1999; 56(6): 1370 - 1373.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Matsuo, K. Tanabe, N. Kioka, T. Amachi, and K. Ueda
Different Binding Properties and Affinities for ATP and ADP among Sulfonylurea Receptor Subtypes, SUR1, SUR2A, and SUR2B
J. Biol. Chem., September 8, 2000; 275(37): 28757 - 28763.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K.-i. Ito, C. J. Oleschuk, C. Westlake, M. Z. Vasa, R. G. Deeley, and S. P. C. Cole
Mutation of Trp1254 in the Multispecific Organic Anion Transporter, Multidrug Resistance Protein 2 (MRP2) (ABCC2), Alters Substrate Specificity and Results in Loss of Methotrexate Transport Activity
J. Biol. Chem., October 5, 2001; 276(41): 38108 - 38114.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.